Analysis of exome sequences with and without incorporating prior biological knowledge
✍ Scribed by Junghyun Namkung; Paola Raska; Jia Kang; Yunlong Liu; Qing Lu; Xiaofeng Zhu
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 101 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0741-0395
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Next‐generation sequencing technology provides new opportunities and challenges in the search for genetic variants that underlie complex traits. It will also presumably uncover many new rare variants, but exactly how these variants should be incorporated into the data analysis remains a question. Several papers in our group from Genetic Analysis Workshop 17 evaluated different methods of rare variant analysis, including single‐variant, gene‐based, and pathway‐based analyses and analyses that incorporated biological information. Although the performance of some of these methods strongly depends on the underlying disease model, integration of known biological information is helpful in detecting causal genes. Two work groups demonstrated that use of a Bayesian network and a collapsing receiver operating characteristic curve approach improves risk prediction when a disease is caused by many rare variants. Another work group suggested that modeling local rather than global ancestry may be beneficial when controlling the effect of population structure in rare variant association analysis. Genet. Epidemiol. 35:S48–S55, 2011. © 2011 Wiley Periodicals, Inc.
📜 SIMILAR VOLUMES
In this study, we assess exome sequencing (ES) as a diagnostic alternative for genetically heterogeneous disorders. Because ES readily identified a previously reported homozygous mutation in the CAPN3 gene for an individual with an undiagnosed limb girdle muscular dystrophy, we evaluated ES as a gen
Serum samples from 20 anti-hepatitis B e antigenpositive patients with and without normal alanine aminotransferase (ALT) levels who had serum hepatitis B virus (HBV) DNA detectable only by polymerase chain reation (PCR) were examined. Viral DNA was amplified by PCR, using primers that encompassed pr